{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:38:55Z","timestamp":1771472335216,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,6]],"date-time":"2011-02-06T00:00:00Z","timestamp":1296950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1477-7819-9-18","type":"journal-article","created":{"date-parts":[[2011,3,2]],"date-time":"2011-03-02T00:01:06Z","timestamp":1299024066000},"source":"Crossref","is-referenced-by-count":94,"title":["Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients"],"prefix":"10.1186","volume":"9","author":[{"given":"Praveen","family":"Ravishankaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Karunanithi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,6]]},"reference":[{"key":"771_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0022-5347(01)62092-5","volume":"161","author":"HL Adler","year":"1999","unstructured":"Adler HL, McCurdy MA, Kattan MW, Timme TL, Scardino PT, Thompson TC: Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol. 1999, 161: 182-187. 10.1016\/S0022-5347(01)62092-5.","journal-title":"J Urol"},{"key":"771_CR2","first-page":"2702","volume":"6","author":"J Nakashima","year":"2000","unstructured":"Nakashima J, Tachibana M, Horiguchi Y, Oya M, Ohigashi T, Asakura H, Murai M: Serum interleukin 6 as a prognostic factor in patients with prostate cancer. Clin Cancer Res. 2000, 6: 2702-2706.","journal-title":"Clin Cancer Res"},{"key":"771_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/S0022-5347(05)67289-8","volume":"164","author":"GJ Wise","year":"2000","unstructured":"Wise GJ, Marella VK, Talluri G, Shirazian D: Cytokine variations in patients with hormone treated prostate cancer. J Urol. 2000, 164: 722-725. 10.1016\/S0022-5347(05)67289-8.","journal-title":"J Urol"},{"key":"771_CR4","first-page":"3317","volume":"52","author":"JY Blay","year":"1992","unstructured":"Blay JY, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, Mercatello A, Ravault A, Tourani JM, Moskovtchenko JF: Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res. 1992, 52: 3317-3322.","journal-title":"Cancer Res"},{"key":"771_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/bjc.1995.71","volume":"71","author":"G Scambia","year":"1995","unstructured":"Scambia G, Testa U, Benedetti Panici P, Foti E, Martucci R, Gadducci A, Perillo A, Facchini V, Peschle C, Mancuso S: Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer. 1995, 71: 354-356. 10.1038\/bjc.1995.71.","journal-title":"Br J Cancer"},{"key":"771_CR6","first-page":"649","volume":"5","author":"F De Vita","year":"1998","unstructured":"De Vita F, Orditura M, Auriemma A, Infusino S, Roscigno A, Catalano G: Serum levels of interleukin 6 as a prognostic factor in advanced non-small cell lung cancer. Oncol Rep. 1998, 5: 649-652.","journal-title":"Oncol Rep"},{"key":"771_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/jama.291.5.585","volume":"291","author":"TP Erlinger","year":"2004","unstructured":"Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ: C-reactive protein and the risk of incident colorectal cancer. JAMA. 2004, 291: 585-590. 10.1001\/jama.291.5.585.","journal-title":"JAMA"},{"key":"771_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00595-007-3680-8","volume":"38","author":"T Nozoe","year":"2008","unstructured":"Nozoe T, Mori E, Takahashi I, Ezaki T: Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surg Today. 2008, 38: 597-602. 10.1007\/s00595-007-3680-8.","journal-title":"Surg Today"},{"key":"771_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ygyno.2007.06.001","volume":"107","author":"S Polterauer","year":"2007","unstructured":"Polterauer S, Grimm C, Tempfer C, Sliutz G, Speiser P, Reinthaller A, Hefler LA: C-reactive protein is a prognostic parameter in patients with cervical cancer. Gynecol Oncol. 2007, 107: 114-117. 10.1016\/j.ygyno.2007.06.001.","journal-title":"Gynecol Oncol"},{"key":"771_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/bjc.1982.62","volume":"45","author":"JL Haybittle","year":"1982","unstructured":"Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI, Griffiths K: A prognostic index in primary breast cancer. Br J Cancer. 1982, 45: 361-366. 10.1038\/bjc.1982.62.","journal-title":"Br J Cancer"},{"key":"771_CR11","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/bjc.1991.477","volume":"64","author":"SW Duffy","year":"1991","unstructured":"Duffy SW, Taba'r L, Fagerberg G, Gad A, South MC, Day NE: Breast screening, prognostic factors and survival--results from the Swedish two county study. Br J Cancer. 1991, 64: 1133-1138. 10.1038\/bjc.1991.477.","journal-title":"Br J Cancer"},{"key":"771_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/bjc.1957.43","volume":"11","author":"HJG Bloom","year":"1957","unstructured":"Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer: a study of 1409 cases of which 539 have been followed up for 15 years. Br J Cancer. 1957, 11: 359-377. 10.1038\/bjc.1957.43.","journal-title":"Br J Cancer"},{"key":"771_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/bjc.1987.230","volume":"56","author":"JH Todd","year":"1987","unstructured":"Todd JH, Dowle C, Williams MR, Elston CW, Ellis IO, Hinton CP, Blamey RW, Haybittle JL: Confirmation of a prognostic index in primary breast cancer. Br J Cancer. 1987, 56: 489-492. 10.1038\/bjc.1987.230.","journal-title":"Br J Cancer"},{"key":"771_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF00666477","volume":"29","author":"U Lonn","year":"1994","unstructured":"Lonn U, Lonn S, Nilsson B, Stenkvist B: Breast cancer: prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features. Breast Cancer Res Treat. 1994, 29: 237-245. 10.1007\/BF00666477.","journal-title":"Breast Cancer Res Treat"},{"key":"771_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ijc.10478","volume":"100","author":"M Hensel","year":"2002","unstructured":"Hensel M, Schneeweiss A, Sinn HP, Egerer G, Solomayer E, Haas R, Bastert G, Ho AD: P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support. Int J Cancer. 2002, 100: 290-296. 10.1002\/ijc.10478.","journal-title":"Int J Cancer"},{"key":"771_CR16","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1200\/JCO.2001.19.7.2010","volume":"19","author":"P Malmstrom","year":"2000","unstructured":"Malmstrom P, Bendahl PO, Boiesen N, Br\u00fcnner N, Idvall I, Fern\u00f6 M: S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histological grade in a prospective study of premenopausal lymph node-negative breast cancer. J Clin Oncol. 2000, 19: 2010-2019.","journal-title":"J Clin Oncol"},{"key":"771_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0140-6736(00)01024-2","volume":"355","author":"L Taba'r","year":"2000","unstructured":"Taba'r L, Chen HH, Duffy SW, Yen MF, Chiang CF, Dean PB, Smith RA: A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet. 2000, 355: 429-433.","journal-title":"Lancet"},{"key":"771_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<449::AID-CNCR13>3.0.CO;2-Q","volume":"86","author":"L Taba'r","year":"1999","unstructured":"Taba'r L, Duffy SW, Vitak B, Chen HH, Prevost TC: The natural history of breast carcinoma: what have we learned from screening?. Cancer. 1999, 86: 449-462.","journal-title":"Cancer"},{"key":"771_CR19","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1074\/jbc.271.2.736","volume":"271","author":"T Cohen","year":"1996","unstructured":"Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ: Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 1996, 271: 736-741. 10.1074\/jbc.271.2.736.","journal-title":"J Biol Chem"},{"key":"771_CR20","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.3748\/wjg.v12.i28.4473","volume":"12","author":"D Thong-Ngam","year":"2006","unstructured":"Thong-Ngam D, Tangkijvanich P, Lerknimitr R, Mahachai V, Theamboonlers A, Poovorawan Y: Diagnostic role of serum interleukin-18 in gastric cancer patients. World J Gastroenterol. 2006, 12: 4473-4477.","journal-title":"World J Gastroenterol"},{"key":"771_CR21","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1002\/ijc.22599","volume":"120","author":"MT Lin","year":"2007","unstructured":"Lin MT, Lin BR, Chang CC, Chu CY, Su HJ, Chen ST, Jeng YM, Kuo ML: IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src\/RhoA\/ROCK signaling pathway. Int J Cancer. 2007, 120: 2600-2608. 10.1002\/ijc.22599.","journal-title":"Int J Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-9-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1477-7819-9-18\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-9-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T09:44:49Z","timestamp":1548150289000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-9-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,6]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["771"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-9-18","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,6]]},"article-number":"18"}}